{"transactions":[{"id":739544,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T16:13:46.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":40000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001372514-26-000061","document":"wk-form4_1781295224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251426000061/wk-form4_1781295224.xml","form_type":"4"}},{"id":1183011,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:14:32.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":30000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001372514-25-000027","document":"wk-form4_1743639259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251425000027/wk-form4_1743639259.xml","form_type":"4"}},{"id":1429116,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T15:45:36.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.96,"value":19800.0,"ownership":{"direct":true},"balance_after":5014,"source":{"system":"sec-edgar","filing":"0001372514-24-000109","document":"wk-form4_1724096730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251424000109/wk-form4_1724096730.xml","form_type":"4"}},{"id":1459653,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T15:15:15.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000088","document":"wk-form4_1720034108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251424000088/wk-form4_1720034108.xml","form_type":"4"}},{"id":1602744,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T06:20:31.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024."}],"balance_after":35000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001516551-24-000022","document":"wk-form4_1709551223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000151655124000022/wk-form4_1709551223.xml","form_type":"4"}},{"id":1748514,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T20:29:14.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":14110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":20001,"derivative":{"exercise_price":3.5,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":14110},"source":{"system":"sec-edgar","filing":"0001516551-23-000092","document":"wk-form4_1699320545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000151655123000092/wk-form4_1699320545.xml","form_type":"4"}},{"id":1767058,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T16:46:33.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000147","document":"wk-form4_1696365983.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251423000147/wk-form4_1696365983.xml","form_type":"4"}},{"id":1794092,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-29T18:22:31.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":1472692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":1472692,"derivative":{"exercise_price":0.014,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":1472692},"source":{"system":"sec-edgar","filing":"0001516551-23-000060","document":"wk-form4_1693347739.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000151655123000060/wk-form4_1693347739.xml","form_type":"4"}},{"id":1965529,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:14:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000031","document":"wf-form4_167823803026213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251423000031/wf-form4_167823803026213.xml","form_type":"4"}},{"id":2058667,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T11:28:00.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 (the \"Grant Date\") and the options will vest in equal monthly installments over the one year period from December 8, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.017,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-23-000014","document":"wf-form4a_167328166436192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000151655123000014/wf-form4a_167328166436192.xml","form_type":"4/A","original_submission_date":"2023-01-06"}},{"id":2060211,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T17:21:16.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 (the \"Grant Date\") and the options will vest in equal monthly installments over the one year period from the Grant Date."}],"balance_after":250000,"derivative":{"exercise_price":0.017,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-23-000006","document":"wf-form4_167304366212912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000151655123000006/wf-form4_167304366212912.xml","form_type":"4"}},{"id":2413378,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:06:10.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011497","document":"tm225348d9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000110465922011497/tm225348d9_4.xml","form_type":"4"}},{"id":2567556,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-09-16T16:01:10.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall be exercisable for a price of $0.12 per Option Share in twelve equal monthly installments such that all the Option Shares shall vest in twelve months."}],"balance_after":275000,"derivative":{"exercise_price":0.12,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-21-018754","document":"wf-form4_163182245212535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000162828021018754/wf-form4_163182245212535.xml","form_type":"4"}},{"id":2624793,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true}}],"security":"Director Option Grant (Right to Buy)","published_at":"2021-07-26T14:23:44.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Options shall be exercisable for a price of $0.14 per Option Share for ten years from July 22, 2021 (the \"Grant Date\") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years."}],"balance_after":250000,"derivative":{"exercise_price":0.14,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-21-025590","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000114036121025590/form4.xml","form_type":"4"}},{"id":2821874,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":28690,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":57380,"derivative":{"underlying":"Common Stock","underlying_shares":28690},"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821873,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":26600,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":26600,"derivative":{"underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821872,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":9727,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9727},"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821871,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2990},"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821870,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":16560,"price":7.19,"value":119066.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":120791,"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821869,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":28690,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":137351,"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821868,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":26600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":108661,"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821867,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":9727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":82061,"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2821866,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2021-03-02T22:00:45.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":72334,"source":{"system":"sec-edgar","filing":"0001127602-21-008777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221008777/form4.xml","form_type":"4"}},{"id":2860074,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T21:41:42.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":96310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":96310,"derivative":{"exercise_price":8.38,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":96310},"source":{"system":"sec-edgar","filing":"0001127602-21-005882","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221005882/form4.xml","form_type":"4"}},{"id":2860073,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2021-02-16T21:41:42.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":32100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":32100,"derivative":{"underlying":"Common Stock","underlying_shares":32100},"source":{"system":"sec-edgar","filing":"0001127602-21-005882","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221005882/form4.xml","form_type":"4"}},{"id":2881350,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T21:53:01.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2022."}],"balance_after":3333,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-21-011849","document":"tm215262-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000110465921011849/tm215262-7_4seq1.xml","form_type":"4"}},{"id":3170458,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2020-04-24T21:20:28.000Z","date":"2020-04-22","kind":"tax_withholding","acquired":false,"shares":4844,"price":1.96,"value":9494.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":69344,"source":{"system":"sec-edgar","filing":"0001127602-20-014494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014494/form4.xml","form_type":"4"}},{"id":3170457,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2020-04-24T21:20:28.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":19893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals."}],"balance_after":74188,"source":{"system":"sec-edgar","filing":"0001127602-20-014494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014494/form4.xml","form_type":"4"}},{"id":3234006,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":26600,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":53200,"derivative":{"underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3234005,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":9726,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":9727,"derivative":{"underlying":"Common Stock","underlying_shares":9726},"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3234004,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":2990,"derivative":{"underlying":"Common Stock","underlying_shares":2990},"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3234003,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":26600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":54295,"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3234002,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":9726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":27695,"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3234001,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2020-03-03T21:17:53.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":17969,"source":{"system":"sec-edgar","filing":"0001127602-20-008968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/form4.xml","form_type":"4"}},{"id":3262665,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T16:32:06.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021."}],"balance_after":3333,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-20-022846","document":"tm209305-6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000110465920022846/tm209305-6_4.xml","form_type":"4"}},{"id":3282947,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T21:14:43.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":258210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":258210,"derivative":{"exercise_price":3.31,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":258210},"source":{"system":"sec-edgar","filing":"0001127602-20-004602","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220004602/form4.xml","form_type":"4"}},{"id":3282946,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2020-02-10T21:14:43.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":86070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":86070,"derivative":{"underlying":"Common Stock","underlying_shares":86070},"source":{"system":"sec-edgar","filing":"0001127602-20-004602","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220004602/form4.xml","form_type":"4"}},{"id":3624087,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:19:39.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":9727,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":19453,"derivative":{"underlying":"Common Stock","underlying_shares":9727},"source":{"system":"sec-edgar","filing":"0001127602-19-009267","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/form4.xml","form_type":"4"}},{"id":3624086,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:19:39.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":5980,"derivative":{"underlying":"Common Stock","underlying_shares":2990},"source":{"system":"sec-edgar","filing":"0001127602-19-009267","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/form4.xml","form_type":"4"}},{"id":3624085,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2019-03-01T22:19:39.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":9727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":14979,"source":{"system":"sec-edgar","filing":"0001127602-19-009267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/form4.xml","form_type":"4"}},{"id":3624084,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2019-03-01T22:19:39.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":5252,"source":{"system":"sec-edgar","filing":"0001127602-19-009267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/form4.xml","form_type":"4"}},{"id":3668839,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2019-02-08T23:13:06.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":79800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":79800,"derivative":{"underlying":"Common Stock","underlying_shares":79800},"source":{"system":"sec-edgar","filing":"0001127602-19-004890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219004890/form4.xml","form_type":"4"}},{"id":3668838,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-08T23:13:06.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":148200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter"}],"balance_after":148200,"derivative":{"exercise_price":5.16,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":148200},"source":{"system":"sec-edgar","filing":"0001127602-19-004890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219004890/form4.xml","form_type":"4"}},{"id":3674147,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T16:37:27.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on February 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005044","document":"tv512444_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000114420419005044/tv512444_form4.xml","form_type":"4"}},{"id":3868573,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-12T16:52:28.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to all of the shares on July 10, 2019."}],"balance_after":61893,"source":{"system":"sec-edgar","filing":"0001144204-18-038183","document":"tv498475_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000114420418038183/tv498475_4.xml","form_type":"4"}},{"id":4021162,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T22:11:52.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":8970,"derivative":{"underlying":"Common Stock","underlying_shares":2990},"source":{"system":"sec-edgar","filing":"0001127602-18-009734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009734/form4.xml","form_type":"4"}},{"id":4021161,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2018-03-02T22:11:52.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":728,"price":8.53,"value":6209.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":2262,"source":{"system":"sec-edgar","filing":"0001127602-18-009734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009734/form4.xml","form_type":"4"}},{"id":4021160,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Common Stock","published_at":"2018-03-02T22:11:52.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":2990,"source":{"system":"sec-edgar","filing":"0001127602-18-009734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009734/form4.xml","form_type":"4"}},{"id":4066537,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T22:17:11.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":82820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter."}],"balance_after":82820,"derivative":{"exercise_price":9.79,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":82820},"source":{"system":"sec-edgar","filing":"0001127602-18-005208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218005208/form4.xml","form_type":"4"}},{"id":4066536,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units","published_at":"2018-02-12T22:17:11.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":29180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":29180,"derivative":{"underlying":"Common Stock","underlying_shares":29180},"source":{"system":"sec-edgar","filing":"0001127602-18-005208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218005208/form4.xml","form_type":"4"}},{"id":4274438,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T16:18:50.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on June 21, 2018."}],"balance_after":15000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-17-033622","document":"v469452_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000114420417033622/v469452_4.xml","form_type":"4"}},{"id":4454524,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-02-13T21:29:36.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":11960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":11960,"derivative":{"underlying":"Common Stock","underlying_shares":11960},"source":{"system":"sec-edgar","filing":"0001127602-17-005429","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217005429/form4.xml","form_type":"4"}},{"id":4454523,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"officer":true,"officer_title":"EVP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-13T21:29:36.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":47860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter"}],"balance_after":47860,"derivative":{"exercise_price":14.44,"expiration_date":"2027-02-09","underlying":"Common Stock","underlying_shares":47860},"source":{"system":"sec-edgar","filing":"0001127602-17-005429","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217005429/form4.xml","form_type":"4"}}]}